Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience.

Biologics · 2019 · PMC6322517 · PMID 30655661

Europe PMC DOI

hedged sentences

0.0470

closest p · 0.9× alpha

0.0470

boldest claim

The sentences

a positive trendP =0.047actually significant

However, we found a positive trend for BMI, with a mild improvement in weight gain in the female subgroup ( P =0.047).

also in 11,005 other papers

showed a trendno p-value reported

BMI showed a trend toward increase ( Figure 6 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.